ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Oncolytics Biotech Inc. 

210-1167 Kensington Crescent

Calgary  Alberta  T2N 1X7  Canada
Phone: 403-670-7374 Fax: 403-283-0858


SEARCH JOBS


Industry
Biotechnology






 Company News
Oncolytics Biotech Inc. (ONC.TO) Announces Phase 1 Study In Pediatric Patients With Brain Tumors 5/19/2015 6:23:34 AM
Oncolytics Biotech Inc. (ONC.TO) Announces 2015 First Quarter Results 5/7/2015 10:45:09 AM
Oncolytics Biotech Inc. (ONC.TO) Announces Receipt Of Orphan Drug Designation From The U.S. FDA For Gastric Cancer 5/6/2015 6:35:05 AM
Oncolytics Biotech Inc. (ONC.TO) Announces Extension To Regain Compliance With Nasdaq's Minimum Bid Price Rule 4/29/2015 7:23:37 AM
Oncolytics Biotech Inc. (ONC.TO) Announces Receipt Of Orphan Drug Status From The European Medicines Agency For Pancreatic Cancer 4/29/2015 6:33:34 AM
Oncolytics Biotech Inc. (ONC.TO) Collaborators Present REOLYSIN Preclinical Data At The 2015 AACR Annual Meeting 4/20/2015 10:34:38 AM
Oncolytics Biotech Inc. (ONC.TO) Announces Receipt Of Orphan Drug Designation From The U.S. FDA For Malignant Gliomas 4/17/2015 6:25:59 AM
Oncolytics Biotech Inc. (ONC.TO) Presents At UK Immuno-Oncology Meeting 4/15/2015 2:24:22 PM
Media Advisory - Oncolytics Biotech Inc. (ONC.TO) To Participate In The 14th Annual Needham Healthcare Conference 4/13/2015 7:24:41 AM
Oncolytics Biotech Inc. (ONC.TO) Announces Filing For Orphan Drug Designation With The U.S. FDA For Gastric Cancer 4/7/2015 6:26:31 AM
12345678910...